{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-113096","form_type":"8-K","ticker":"SEM","cik":"0001320414","company_name":"SELECT MEDICAL HOLDINGS CORP","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.077388+00:00","generated_at":"2026-05-30T07:19:48.986616+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Select Medical Q3 revenue up 5.7% to $1.76B; net income +33.2%; dividend $0.125; FY guidance updated","bullets":["Q3 revenue $1,761.2M (+5.7% YoY); net income $81.0M (+33.2%); adjusted EPS $0.50 (+8.7%).","Segment Adj. EBITDA: Critical Illness +9.5%, Rehab Hospital +12.1%, Concentra +2.7%.","FY2024 guidance: revenue $6.95B–$7.15B; Adj. EBITDA $865M–$885M; adj. EPS $2.09–$2.20.","Dividend $0.125/share declared, payable Nov 26 to holders of record Nov 13, 2024.","No share repurchases in Q3; $600.3M total buybacks since program inception."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-113096","json":"https://secwatch.observer/filing/0001104659-24-113096.json","markdown":"https://secwatch.observer/filing/0001104659-24-113096.md","text":"https://secwatch.observer/filing/0001104659-24-113096.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1320414/000110465924113096/0001104659-24-113096-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1320414/000110465924113096/tm2427100d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:19:48.986616+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}